BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results

  Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided key business updates.

  March 1, 2022

   · 

  14 min read
• Drug Development

  Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

  Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints.

  March 1, 2022

   · 

  10 min read
• Genetown

  EyePoint Pharmaceuticals to Participate in Fireside Chat at the Cowen 42nd Annual Health Care Conference

  EyePoint Pharmaceuticals, Inc. announced that Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals, will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 10:30 a.m. ET.

  March 1, 2022

   · 

  1 min read
• Genetown

  iTeos to Present at the Cowen 42nd Annual Health Care Conference

  iTeos Therapeutics, Inc. today announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 12:50 p.m. ET.

  March 1, 2022

   · 

  2 min read
• Pharm Country

  Passage Bio to Participate in Upcoming March 2022 Investor Conferences

  Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, announced that management will participate in two upcoming virtual investor conferences in March.

  March 1, 2022

   · 

  1 min read
• Business

  Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

  Epizyme today reported fourth quarter and full year 2021 financial results and provided business and portfolio updates.

  March 1, 2022

   · 

  19 min read
• Genetown

  AVROBIO to Present at Two Upcoming Investor Conferences in March

  AVROBIO to Present at Two Upcoming Investor Conferences in March.

  March 1, 2022

   · 

  5 min read
• BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference

  BELLUS Health Inc. announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a panel at the Cowen & Co. 42nd Annual Health Care Conference.

  March 1, 2022

   · 

  1 min read
• Biotech Bay

  XOMA to Present at the 42nd Annual Cowen Health Care Conference

  XOMA Corporation announced its Chairman and Chief Executive Officer, Jim Neal, will be featured in a fireside chat at the 42nd Annual Cowen Health Care Conference on Monday, March 7, 2022, at 1:30 PM ET.

  March 1, 2022

   · 

  1 min read
• Business

  Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance

  Horizon Therapeutics plc (Nasdaq: HZNP) today announced fourth-quarter and record full-year 2021 financial results and provided full-year 2022 net sales and adjusted EBITDA guidance.

  March 1, 2022

   · 

  52 min read